Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update

NEXT STORY
Polymerase Chain Reaction (PCR) Market to Exhibit 8.3% CAGR by 2026: Advent of Digital PCR is Promoting Growth, Reports Fortune Business Insights™
PREV STORY
Immutep Reports Supportive Efficacy Data from the Phase IIb AIPAC Study; Overall Survival Data Expected in Late 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Innovations Form Partnership to Develop a Novel Gene Therapy Treatment for Cystic Fibrosis

Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Innovations Form ...

author_avatar
NASDAQ Market News

Network Theory Links Behavioral Information Flow with Contained Epidemic Outbreaks

Philadelphia, PA, June 14, 2018 (GLOBE NEWSWIRE) -- Over the last two decades, large-scale ...

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Additional Data from Positive Phase III Study of RHB-104 in Crohn’s Disease at United European Gastroenterology (UEG) Week 2018

The presentation highlighted enhanced p-values for previously reported outcomes, including the primary endpoint of ...

author_avatar
NASDAQ Market News